melatonin | Evidence search | NICE

Filter results by

Guidance and Policy (337)
Guidance (45)
Policy and Strategy (1)
Prescribing and Technical Information (288)
Safety Alerts (4)
Secondary Evidence (268)
Systematic Reviews (149)
Economic Evaluations (1)
Evidence Summaries (104)
Health Technology Assessments (2)
Horizon Scanning (3)
Evidence Uncertainties (9)
Primary Research (59)
Ongoing Trials (6)
Medicines Current Awareness (11)
Implementation Support (4)
Information for the Public (36)

Area of interest

Clinical (591)
Commissioning and Management (20)
Drugs and Technologies (403)
Public Health (53)
Social Care (20)

Source

Age UK (3)
American Academy of Neurology (2)
Arthritis Research UK (1)
BestBETS (3)
Brain Tumour Charity (3)
British Association for Psychopharmacology - BAP (4)
British Geriatrics Society - BGS (1)
British National Formulary - BNF (129)
British National Formulary for Children - BNFc (128)
Canadian Paediatric Society (4)
Clinical Knowledge Summaries (4)
Cochrane Central Register of Controlled Trials (26)
Cochrane Clinical Answers (4)
Cochrane Database of Systematic Reviews (26)
Database of Abstracts of Reviews of Effects - DARE (27)
Ehlers-Danlos Support UK (1)
electronic Medicines Compendium - eMC (4)
Epilepsy Action (2)
European Association of Urology - EAU (2)
European Medicines Agency - EMA (4)
European Monitoring Centre for Drugs and Drug Addiction (3)
Faculty of Sexual and Reproductive Healthcare (1)
FoNs Centre for Nursing Innovation (1)
GeneReviews (4)
GOV UK (5)
Healthcare Improvement Scotland (1)
Healthtalkonline (5)
Intensive Care Society - ICS (1)
International Association for the Study of Pain (2)
James Lind Alliance (1)
Lymphoma Action (1)
Macmillan Cancer Support (2)
Medicines and Healthcare products Regulatory Agency - MHRA (7)
Medicines for Children (1)
Medicines Management Collection (14)
National Cancer Institute, USA (3)
National Institute for Health and Care Excellence - NICE (20)
National Institute of Environmental Health Sciences (2)
NHS Economic Evaluation Database - NHS EED (1)
NHS England (1)
NHS website (15)
NIHR Dissemination Centre (1)
NIHR Innovation Observatory (1)
NIHR Journals Library - Health Technology Assessment (2)
Orphanet (1)
Parliamentary Office of Science and Technology (2)
Patient (18)
PrescQIPP (1)
Public Health England - PHE (3)
PubMed (38)
Royal College of Psychiatrists - RCPsych (4)
Royal Society for Public Health (2)
Royal Society for the Encouragement of Arts, Manufactures and Commerce - RSA (1)
SCIE Social Care Online (1)
Scottish Intercollegiate Guidelines Network - SIGN (3)
Scottish Medicines Consortium - SMC (1)
Specialist Pharmacy Service (44)
UK Clinical Trials Gateway - UKCTG (6)
UK Database of Uncertainties about the Effects of Treatments - UK DUETS (7)
US Food and Drug Administration - FDA (1)
WHO Regional Office for Europe - WHO Europe (1)
World Health Organization (1)

Date

From

To

Accredited

View filters

Share
Linked In
Twitter
Facebook
Email
More...

Results 1 - 10 of 710 sorted by relevance / date

Click export CSV or RIS to download the entire page or use the checkboxes to select a subset of records to download

Warning, download options selected.

The operation that you have selected will move away from the current results page, your download options will not persist.

Please click "Confirm" if you are happy to lose these search results.

Melatonin for the management of sleep disorders in children and adolescents

Source: Canadian Paediatric Society - 31 May 2012 - Publisher: Canadian Paediatric Society

Problems of sleep initiation and maintenance occur in 15% to 25% of children and adolescents. Studies of the benefits of melatonin for sleep disorders have been published for healthy populations, ...

Read Summary

- More: Guidance
MELATONIN | Drug | BNF content published by NICE

Source: British National Formulary - BNF - 02 November 2018

Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for MELATONIN.

More: Prescribing and Technical Information
Bulletin 108 Melatonin (SPOT-List)

Source: PrescQIPP - 16 August 2016 - Publisher: PrescQIPP

The Melatonin SPOT-List support document reviews the place in therapy for melatonin and recommends reviewing patients regularly to assess for continued need. A shared care template document is...

Read Summary

- More: Prescribing and Technical Information
Melatonin | Interactions | BNF content published by NICE

Source: British National Formulary - BNF - 02 November 2018

A list of drugs that interact with Melatonin.

More: Prescribing and Technical Information
Melatonin 10mg capsules: Company-led recall

Source: Medicines and Healthcare products Regulatory Agency - MHRA - Source: GOV UK - 17 July 2018 - Publisher: Medicines and Healthcare products Regulatory Agency

IPS Specials are recalling specific batches of Melatonin 10 mg capsules because they have been assigned an incorrect extended expiry date.

Read Summary

- More: Safety Alerts
MELATONIN | Drug | BNFc content published by NICE

Source: British National Formulary for Children - BNFc - 02 November 2018

Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for MELATONIN.

More: Prescribing and Technical Information
Melatonin | Interactions | BNFc content published by NICE

Source: British National Formulary for Children - BNFc - 02 November 2018

A list of drugs that interact with Melatonin.

More: Prescribing and Technical Information
Melatonin for sleep problems in children with neurodevelopmental disorders

15 October 2015 - Publisher: Drug and Therapeutics Bulletin

This reviews off-label and unlicensed use of melatonin in children with attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder or related neurodevelopmental disorders. See also...

Read Summary

- More: Evidence Summaries
Melatonin and melatonin agonist for delirium in the elderly patients

Source: Database of Abstracts of Reviews of Effects - DARE - 23 October 2014

Melatonin and melatonin agonist for delirium in the elderly patients var _gaq = _gaq || [];

More: Systematic Reviews
Does melatonin improve sleep in children with neurodevelopmental disorders?

08 October 2018 - Publisher: Drug and Therapeutics Bulletin

This review summarises the evidence from a systematic review of 13 RCTs (n=682) which found that total sleep time was higher with melatonin vs placebo (mean difference 48 min; 95% CI 37-60). There...

Read Summary

- More: Evidence Summaries

- More: Medicines Current Awareness

1
2
3
4
5
6
7
Next

About Evidence Search

NICE Pathways
Guidance
Standards & Indicators
Evidence services

Follow Us

About
Accessibility
Freedom of information
Contact Us
Glossary
Terms and conditions
Subscribe

© NICE 2018. All rights reserved. Subject to Notice of rights.